104 related articles for article (PubMed ID: 5797591)
1. Comparative price list: generic vs brand name drugs.
Md State Med J; 1969 Jul; 18(7):89-91. PubMed ID: 5797591
[No Abstract] [Full Text] [Related]
2. The effect of generic competition on the price of brand-name drugs.
Lexchin J
Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
[TBL] [Abstract][Full Text] [Related]
3. [Generic name or brand name?].
Madsen S
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):431. PubMed ID: 16477277
[No Abstract] [Full Text] [Related]
4. Physician use of brand versus generic drug names in 1993-1994 and 2003-2004.
Kwo EC; Kamat P; Steinman MA
Ann Pharmacother; 2009 Mar; 43(3):459-68. PubMed ID: 19261956
[TBL] [Abstract][Full Text] [Related]
5. Generically speaking.
Drug Ther Bull; 2009 Oct; 47(10):109. PubMed ID: 19809083
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
McManus P; Birkett DJ; Dudley J; Stevens A
Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
[TBL] [Abstract][Full Text] [Related]
7. Generic terminology and the cost of drugs.
Friend DG; Goolkasian AR; Hassan WE; Vona JP
JAMA; 1969 Jul; 209(1):80-4. PubMed ID: 5819262
[No Abstract] [Full Text] [Related]
8. Trends in manufacturer prices of brand name prescription drugs used by older Americans--first quarter 2004 update.
Gross DJ; Schondelmeyer SW; Raetzman SO
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB69):1-12, 1-2. PubMed ID: 15368653
[TBL] [Abstract][Full Text] [Related]
9. FDA drug list: key to generic substitution.
FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
[TBL] [Abstract][Full Text] [Related]
10. Authorized generic drugs, price competition, and consumers' welfare.
Berndt ER; Mortimer R; Bhattacharjya A; Parece A; Tuttle E
Health Aff (Millwood); 2007; 26(3):790-9. PubMed ID: 17485758
[TBL] [Abstract][Full Text] [Related]
11. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
12. Generic vs. brand name drugs--quality, not cost, is key issue.
Stetler CJ
Internist; 1979 May; 20(4):9-10, 12. PubMed ID: 10242133
[No Abstract] [Full Text] [Related]
13. Effect of generic-only drug benefits on seniors' medication use and financial burden.
Tseng CW; Brook RH; Keeler E; Steers WN; Waitzfelder BE; Mangione CM
Am J Manag Care; 2006 Sep; 12(9):525-32. PubMed ID: 16961441
[TBL] [Abstract][Full Text] [Related]
14. [Prescription by INN (International Non-Proprietary Name)].
Elsen C; Nève J; Schetgen M
J Pharm Belg; 2005; 60(3):77-83. PubMed ID: 16252508
[No Abstract] [Full Text] [Related]
15. Generics: what's in a name?
Keith LG; Oleszczuk JJ; Stika CS; Stine S
Int J Fertil Womens Med; 1998; 43(3):139-49. PubMed ID: 9692536
[TBL] [Abstract][Full Text] [Related]
16. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
Kong Y
Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
[TBL] [Abstract][Full Text] [Related]
17. Dispensing pattern of generic and brand-name drugs in children.
Chen AY; Wu S
Ambul Pediatr; 2008; 8(3):189-94. PubMed ID: 18501866
[TBL] [Abstract][Full Text] [Related]
18. Effect of generic drug competition on the price of prescription drugs in Ontario.
Lexchin J
CMAJ; 1993 Jan; 148(1):35-8. PubMed ID: 8439888
[TBL] [Abstract][Full Text] [Related]
19. Financial incentives and physicians' prescription decisions on the choice between brand-name and generic drugs: evidence from Taiwan.
Liu YM; Yang YH; Hsieh CR
J Health Econ; 2009 Mar; 28(2):341-9. PubMed ID: 19091433
[TBL] [Abstract][Full Text] [Related]
20. Generic vs. brand name drugs--patients, pharmacists, physicians: caught in the middle.
Felch WC
Internist; 1979 May; 20(4):3-5. PubMed ID: 10242131
[No Abstract] [Full Text] [Related]
[Next] [New Search]
